Search

everythinglearnresearchcommunity

for

Search:↓

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Dutasteride improved both hair loss and acne in two young men.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Biofibre hair implant is a safe, effective treatment for baldness with 95% patient satisfaction.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Acne is a common skin condition treated with creams, antibiotics, and emerging therapies, and it can significantly affect mental well-being.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Hormonal imbalances can cause acne, and treatments may include hormone-blocking medications.